Zentiva to look at Sanofi-Aventis's takeover offer
This article was originally published in Scrip
Executive Summary
Zentiva, the largest pharmaceutical manufacturer in the Czech Republic, says it will consider the takeover offer made by Sanofi-Aventis Europe, a wholly owned subsidiary ofSanofi-Aventis, which is proposing to acquire Zentiva's shares at a price of CK1,050 ($71.4) each.